Casting, taping or stretching after botulinum toxin type A for spastic equinus foot: A single-blind randomized trial on adult stroke patients

Clinical Rehabilitation

Volumn 25, Issue 12, 2011, Pages 1119-1127

  Carda, Stefano ^a   Invernizzi, Marco ^a   Baricich, Alessio ^a   Cisari, Carlo ^a,b  

^a Physical and Rehabilitative Medicine   (Italy)

^b Azienda Ospedaliera Universitaria 'Maggiore della Carita' ^*  (Italy)

Author keywords

Botulinum toxin; Casting; Hemiplegia; Spasticity; stretching

Indexed keywords

BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

ARTICLE; ATHLETIC TAPE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PES EQUINUS; PLASTER CAST; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SPASTICITY; STRETCHING EXERCISE;

ATHLETIC TAPE; BOTULINUM TOXINS, TYPE A; CASTS, SURGICAL; COMBINED MODALITY THERAPY; EQUINUS DEFORMITY; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE SPASTICITY; MUSCLE STRETCHING EXERCISES; NEUROMUSCULAR AGENTS; SINGLE-BLIND METHOD;

EID: 83455231477     PISSN: 02692155     EISSN: 14770873     Source Type: Journal    
DOI: 10.1177/0269215511405080     Document Type: Article

References (34)

1. Lance JW. The control of muscle tone, reflexes and movement: Robert Wartenberg Lecture. Neurology. 1980 ; 30: 1303-13 (Pubitemid 11209184)
2. Urban PP, Wolf T, Uebele M, et al. Occurrence and clinical predictors of spasticity after ischemic stroke. Stroke. 2010 ; 41: 2016-20
3. Watkins CL, Leathley MJ, Gregson JM, Moore AP, Smith TL, Sharma AK. Prevalence of spasticity post stroke. Clin Rehabil. 2002 ; 16: 515-22
4. Francisco GE. How common is spastic hypertonia during stroke rehabilitation?. Arch Phys Med Rehabil. 2002 ; 83: 1644-5
5. Lamontagne A, Malouin F, Richards CL. Locomotor-specific measure of spasticity of plantarflexor muscles after stroke. Arch Phys Med Rehabil. 2001 ; 82: 1696-704 (Pubitemid 33126676)
6. Das TK, Park DM. Botulinum toxin in treating spasticity. Br J Clin Pract. 1989 ; 43: 401-3 (Pubitemid 20002238)
7. Hesse S, Lucke D, Malezic M, et al. Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients. J Neurol Neurosurg Psychiatry. 1994 ; 57: 1321-4 (Pubitemid 24342295)
8. Turkel CC, Bowen B, Liu J, Brin MF. Pooled analysis of the safety of botulinum toxin type A in the treatment of poststroke spasticity. Arch Phys Med Rehabil. 2006 ; 87: 786-92 (Pubitemid 43767710)
9. Rodriquez AA, McGinn M, Chappell R. Botulinum toxin injection of spastic finger flexors in hemiplegic patients. Am J Phys Med Rehabil. 2000 ; 79: 44-7 (Pubitemid 30075098)
10. Hesse S, Reiter F, Konrad M, Jahnke MT. Botulinum toxin type A and short-term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: a randomized, double-blind, placebo-controlled trial. Clin Rehabil. 1998 ; 12: 381-8 (Pubitemid 28464099)
11. Hesse S, Werner C, Bardeleben A, Brandl-Hesse B. Management of upper and lower limb spasticity in neuro-rehabilitation. Acta Neurochir Suppl. 2002 ; 79:
12. Reiter P, Danni M, Lagalla G, Ceravolo G, Provinciali L. Low-dose botulinum toxin with ankle taping for the treatment of spastic equinovarus foot after stroke. Arch Phys Med Rehabil. 1998 ; 79: 532-5 (Pubitemid 28222165)
13. Baricich A, Carda S, Bertoni M, Maderna L, Cisari C. A single-blinded, randomized pilot study of botulinum toxin type A combined with non-pharmacological treatment for spastic foot. J Rehabil Med. 2008 ; 40: 870-2
14. Carda S, Molteni F. Taping versus electrical stimulation after botulinum toxin type A injection for wrist and finger spasticity. A case-control study. Clin Rehabil. 2005 ; 19: 621-6 (Pubitemid 41309589)
15. Albany K. Physical and occupational therapy considerations in adult patients receiving botulinum toxin injections for spasticity. Muscle Nerve. 1997 ; 20 (suppl 6). S221-31
16. Yablon SA, Agana BT, Ivanhoe CB, Boake C. Botulinum toxin in severe upper extremity spasticity among patients with traumatic brain injury: an open-labeled trial. Neurology. 1996 ; 47: 939-44
17. Ward AB, Aguilar M, De Beyl Z, et al. Use of botulinum toxin type A in management of adult spasticity-a European consensus statement. J Rehabil Med. 2003 ; 35: 98-9 (Pubitemid 36329202)
18. Verplancke D, Snape S, Salisbury CF, Jones PW, Ward AB. A randomized controlled trial of botulinum toxin on lower limb spasticity following acute acquired severe brain injury. Clin Rehabil. 2005 ; 19: 117-25 (Pubitemid 40309182)
19. Yaşar E, Tok F, Safaz I, Balaban B, Yilmaz B, Alaca R. The efficacy of serial casting after botulinum toxin type A injection in improving equinovarus deformity in patients with chronic stroke. Brain Inj. 2010 ;: 1-4
20. Farina S, Migliorini C, Bertolasi L, et al. Combined effects of botulinum toxin and casting treatments on lower limb spasticity after stroke. Funct Neurol. 2008 ; 23: 87-91
21. Bohannon RW, Smith MB. Interrater reliability on a modified Ashworth scale of muscle spasticity. Phys Ther. 1987 ; 67: 206-7 (Pubitemid 17026064)
22. Richardson D, Sheean G, Werring D, et al. Evaluating the role of botulinum toxin in the management of focal hypertonia in adults. J Neurol Neurosurg Psychiatry. 2000 ; 69: 499-506
23. Committee on Proficiency Standards for Clinical Pulmonary Functional Laboratories ATS. ATS Statement: guidelines for the 6-minute walk test. Am J Respir Crit Care Med. 2002 ; 166: 111-17
24. Brandstater ME, de Bruin H, Gowland C, Clark BM. Hemiplegic gait: analysis of temporal variables. Arch Phys Med Rehabil. 1983 ; 64:
25. Green J, Forster A, Young J. Reliability of gait speed measured by a timed walking test in patients one year after stroke. Clin Rehabil. 2002 ; 16: 306-14 (Pubitemid 34467222)
26. Holden MK, Gill KM, Magliozzi MR, Nathan J, Piehl-Baker L. Clinical gait assessment in the neurologically impaired. Reliability and meaningfulness. Phys Ther. 1984 ; 64: 35-40 (Pubitemid 14219736)
27. Wade D Measurement in neurological rehabilitation. Wade DT, ed. Oxford: Oxford University Press ; 1992: 50-8.
28. Bottos M, Benedetti MG, Salucci P, Gasparroni V, Giannini S. Botulinum toxin with and without casting in ambulant children with spastic diplegia: a clinical and functional assessment. Dev Med Child Neurol. 2003 ; 45: 758-62 (Pubitemid 37304065)
29. Hayek S, Gershon A, Wientroub S, Yizhar Z. The effect of injections of botulinum toxin type A combined with casting on the equinus gait of children with cerebral palsy. J Bone Joint Surg Br. 2010 ; 92-B: 1152-9
30. Fridén J, Lieber RL. Spastic muscle cells are shorter and stiffer than normal cells. Muscle Nerve. 2003 ; 27: 157-64 (Pubitemid 36169326)
31. Abrams RA, Tsai AM, Watson B, Jamali A, Lieber RL. Skeletal muscle recovery after tenotomy and 7-day delayed muscle length restoration. Muscle Nerve. 2000 ; 23: 707-14 (Pubitemid 30256601)
32. Toursel T, Stevens L, Granzier H, Mounier Y. Passive tension of rat skeletal soleus muscle fibers: effects of unloading conditions. J Appl Physiol. 2002 ; 92: 1465-72 (Pubitemid 34670900)
33. Tyson SF, Connell L. The psychometric properties and clinical utility of measures of walking and mobility in neurological conditions: a systematic review. Clin Rehabil. 2009 ; 23: 1018-33
34. Schroeder AS, Ertl-Wagner B, Britsch S, et al. Muscle biopsy substantiates long-term MRI alterations one year after a single dose of botulinum toxin injected into the lateral gastrocnemius muscle of healthy volunteers. Mov Disord. 2009 ; 24: 1494-503